03: Big Pharma | Cure for Cancer | Conspiracy Cabal Podcast
March 17, 2026
88
6
1
7.95%
Search the Record
IndexedEvery word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
Conspiracycabalpodcast Episodes Around March 17, 2026
See what was published immediately before and after this episode.
40:3501: The Mystery of Westall | UFOs in Melbourne | Conspiracy Cabal Podcast
37:39Now Playing03: Big Pharma | Cure for Cancer | Conspiracy Cabal Podcast
YouTube Description
as posted by the channelConspiracy Cabal is proudly supported by WholeLife. Use code CABAL10 for $10 off your first order of $50 or more.
Would you take medical advise from Mel Gibson? The answer is hopefully no, but you should listen to the episode anyway.
From patent games to profit margins that make tech monopolies blush, the pharmaceutical industry has been accused of putting shareholder returns ahead of patient lives for decades. But is Big Pharma actively suppressing a cure for cancer to protect their treatment goldmine?
Join hosts Richard Baker and Dr. Nick Coatsworth as they separate genuine pharmaceutical industry failures from fantasy, examining what the evidence actually reveals about corporate incentives, medical research, and whether your chemotherapy is profitable by design.
The Conspiracy Cabal doesn't promote conspiracy theories - we examine them. We search for the kernel of truth in every story, exploring how conspiracies start, why they persist, and what drives people to believe them.
Contact the show at conspiracycabal@outlook.com
Guests & Subjects Covered
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.